PL3522921T3 - Zapobieganie alergii - Google Patents

Zapobieganie alergii

Info

Publication number
PL3522921T3
PL3522921T3 PL17781085T PL17781085T PL3522921T3 PL 3522921 T3 PL3522921 T3 PL 3522921T3 PL 17781085 T PL17781085 T PL 17781085T PL 17781085 T PL17781085 T PL 17781085T PL 3522921 T3 PL3522921 T3 PL 3522921T3
Authority
PL
Poland
Prior art keywords
allergy
prevention
Prior art date
Application number
PL17781085T
Other languages
English (en)
Inventor
Thierry Legon
Gaetan THIRION
Original Assignee
Asit Biotech S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60043193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3522921(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asit Biotech S.A. filed Critical Asit Biotech S.A.
Publication of PL3522921T3 publication Critical patent/PL3522921T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL17781085T 2016-10-05 2017-10-05 Zapobieganie alergii PL3522921T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP16192425 2016-10-05
EP17171268 2017-05-16
EP17781085.0A EP3522921B1 (en) 2016-10-05 2017-10-05 Prevention of allergy
PCT/EP2017/075398 WO2018065538A1 (en) 2016-10-05 2017-10-05 Prevention of allergy

Publications (1)

Publication Number Publication Date
PL3522921T3 true PL3522921T3 (pl) 2021-10-18

Family

ID=60043193

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17781085T PL3522921T3 (pl) 2016-10-05 2017-10-05 Zapobieganie alergii

Country Status (11)

Country Link
US (1) US20200222530A1 (pl)
EP (1) EP3522921B1 (pl)
JP (1) JP2019530702A (pl)
CN (1) CN109890414A (pl)
AU (1) AU2017341096A1 (pl)
BR (1) BR112019006844A2 (pl)
CA (1) CA3039101A1 (pl)
DK (1) DK3522921T3 (pl)
ES (1) ES2868631T3 (pl)
PL (1) PL3522921T3 (pl)
WO (1) WO2018065538A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2019018529A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. METHODS OF MAKING MIXED ALLERGEN COMPOSITIONS
AU2020213085A1 (en) 2019-01-23 2021-08-12 Société des Produits Nestlé S.A. Methods for making mixed allergen compositions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247614A (en) 1969-06-20 1971-09-29 Miles Lab Improved therapeutic and diagnostic allergenic extract and process for preparing same
US4822611A (en) 1986-12-09 1989-04-18 Immunotec, Inc. Oral hyposensitization in the treatment of allergies
AU675629B2 (en) 1992-09-21 1997-02-13 Laboratorios Leti S.A. A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use
BE1011033A6 (fr) 1997-03-05 1999-04-06 Univ Bruxelles Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
CZ302352B6 (cs) 1997-10-30 2011-03-30 C. B. F. Leti, S. A. Zpusob prípravy extraktu poskytujících toleranci proti alergenu a jejich použití
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
RU2010129082A (ru) 2007-12-14 2012-01-20 Нестек С.А. (Ch) Гипоаллергенный белок злаков и его применение
US20100278880A1 (en) * 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
CN105660883A (zh) 2009-10-16 2016-06-15 澳大利亚乳品有限公司 使用酸处理的乳清蛋白提取物水溶液治疗过敏症
WO2011150949A1 (en) 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2436389A1 (en) 2010-10-01 2012-04-04 Nestec S.A. Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
EP2721051B1 (en) * 2011-06-15 2017-11-29 ASIT BioTech s.a. A method for the production of hydrolyzed allergens
EP2734231A1 (en) 2011-07-21 2014-05-28 Biotech Tools S.A. Dosage of dnak
EP2976107B1 (en) * 2013-03-19 2019-02-20 ASIT BioTech s.a. Allergen preparation
PL3129001T3 (pl) * 2014-04-10 2020-06-29 Asit Biotech S.A. Preparat alergenów wolny od hsp
CN107404922B (zh) 2015-03-30 2021-09-14 雀巢产品有限公司 乳基蛋白质水解物及由其制备的组合物

Also Published As

Publication number Publication date
CN109890414A (zh) 2019-06-14
WO2018065538A1 (en) 2018-04-12
EP3522921B1 (en) 2020-12-23
CA3039101A1 (en) 2018-04-12
AU2017341096A1 (en) 2019-04-04
DK3522921T3 (da) 2021-03-29
EP3522921A1 (en) 2019-08-14
US20200222530A1 (en) 2020-07-16
ES2868631T3 (es) 2021-10-21
BR112019006844A2 (pt) 2019-06-25
JP2019530702A (ja) 2019-10-24

Similar Documents

Publication Publication Date Title
ZA201807517B (en) Validation of pal protection areas
IL257026A (en) Solid state forms of eluxadoline
GB2578811B (en) Devices formed of interconnected components
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
IL265628A (en) Solid state forms of valbenazine
PT3661491T (pt) 3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica
ZA201706282B (en) Solid forms of menaquinols
GB201413530D0 (en) Treatment and prevention of malaria
PL3522921T3 (pl) Zapobieganie alergii
SI3081228T1 (sl) Irizin za nego in preprečitev osteoporoze
PT3320901T (pt) Dimetilaminomicheliolida para utilização no tratamento de fibrose pulmonar
SMT202400084T1 (it) Composizione per la prevenzione e/o il trattamento dei sintomi dell’allergia
GB201615298D0 (en) Treatment and prevention of Malaria
LT3430390T (lt) Molekulinė alergijos kilmė
GB2544217B (en) Chlorination of sucrose-6-esters
PT3471835T (pt) Utilização de extratos de deschampsia antarctica para combater danos na barreira cutânea humana provocados por agressões ambientais
IL254666A0 (en) Crystalline forms of Aldecalcitol
GB201721386D0 (en) Chrondogy of time-wave
IL260901A (en) Safe allergy
GB201701233D0 (en) Field of invention
GB201511584D0 (en) Viprodi - Goblet of Fire
GB201512384D0 (en) Remote configuration of devices
GB201600187D0 (en) 3rd law of time - de-constructed
GB201405142D0 (en) Theory of restoration